CONGRESS ABSTRACT

Continuous monitoring of cardiac arrhythmias is crucial for diagnosing and managing cardiovascular diseases. Timely detection and interpretation of rhythm abnormalities can prevent severe adverse events, thus improving patients' quality of life. In this context, Biotronik’s BioMonitor IV represents a significant technological innovation. This subcutaneous loop recorder is designed to continuously record the heart’s electrical activity, utilizing advanced artificial intelligence (AI) algorithms for real-time data analysis. AI is revolutionizing cardiology, enabling unprecedented diagnostic precision and superior operational efficiency. This abstract focuses on the integration of AI in BioMonitor IV and its potential impact on clinical and nursing practice. BioMonitor IV is implanted under the patient's skin and continuously records the electrocardiogram (ECG) for extended periods. The use of AI algorithms allows the device to autonomously analyze collected data, accurately identifying and signaling arrhythmic events. This significantly reduces false positives and negatives compared to traditional monitoring methods, thereby improving diagnostic accuracy. Additionally, the AI technology integrated into BioMonitor IV facilitates more efficient data management and advanced decision support for physicians. The nurse's role in managing patients with cardiac monitoring devices is crucial. Nurses are often the first to respond to data transmitted by loop recorders, and their ability to interpret this data and act promptly can make the difference between effective management and delayed intervention. With BioMonitor IV, AI not only enhances monitoring accuracy but also provides advanced tools to help nurses better manage workloads and ensure high-quality patient care.